SCHEMBL6022189

SCHEMBL6022189

CCCCCCN(Cc1ccncc1)C1CCN([S+]([O-])c2ccc(CNC(=O)c3ccc(Cl)cc3)s2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.36
MAPK14 Q16539 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
DRD2 P14416 4/20 0.35
DRD3 P35462 4/20 0.35
DRD4 P21917 2/20 0.35
NR1D1 P20393 2/20 0.34
MAPK9 P45984 1/20 0.34
MAPK10 P53779 1/20 0.34
NR1H3 Q13133 1/20 0.34
NR1D2 Q14995 1/20 0.34
NAAA Q02083 1/20 0.34
CXCR3 P49682 1/20 0.34
ACKR3 P25106 1/20 0.33
KCNH2 Q12809 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139807 0.91 DRD2 (0.38) HTTSMN1; SMN2LMNADRD2DRD3
SCHEMBL6021656 0.87 DRD2 (0.39) DRD2DRD3DRD4MAPK9MAPK10
SCHEMBL7146894 0.87 TMEM97 (0.40) DRD2DRD3DRD4MAPK9MAPK10
SCHEMBL6021776 0.86 MAPK9 (0.33) SMN1; SMN2LMNADRD2DRD3DRD4
SCHEMBL3480185 0.84 MAPK9 (0.51) CYP3A4MAPK14SMN1; SMN2LMNADRD2
SCHEMBL3479946 0.78 MAPK9 (0.51) SMN1; SMN2LMNAMAPK9MAPK10TRPV1
SCHEMBL3479709 0.77 MAPK9 (0.54) LMNADRD2DRD3DRD4MAPK9
SCHEMBL7142563 0.75 TP53 (0.44) SMN1; SMN2LMNA
SCHEMBL7139566 0.75 KDM4E (0.42) HTTSMN1; SMN2MAPK9MAPK10
SCHEMBL6021494 0.73 ACKR3 (0.38) SMN1; SMN2LMNAACKR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663193-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES Applied Research Systems ARS Holding N.V. (AN) 2006-06-07 EP disclosed
WO-2005025558-A1 SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES APPLIED RESERACH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO disclosed